The Drugs Controller General of India had granted permission for conducting the phase 2/3 clinical trial of Bharat Biotech's Covaxin among children aged two to 18 years on 12 May.
On the International Clinical Trial Day, here’s a look at the man behind the first clinical trial, who was prompted to launch the survey by his need to study Scurvy.
An expert group of WHO may have advocated for the continued use of blinded placebo-controlled studies for ‘reliable evidence’, but scientific community thinks otherwise.
Experts say more clinical trials are needed in India for those who’ve exhausted available treatment, and to help establish therapies that work best for Indians. But hurdles remain.
The Drug Controller General of India has in the past rejected several applications from other drugmakers, including Dr Reddy Laboratory and Natco Pharma.
ED has accused Amtek promoter Arvind Dham of controlling web of nearly 500 shell companies operating as a layered structure, with up to 15 levels of indirect ownership, to divert funds.
Bengaluru-based CeNS designs accurate, portable, and cheap sensor using surface-enhanced Raman spectroscopy. It could significantly reduce risks at vulnerable choke points.
From Munir’s point of view, a few bumps here and there is par for the course. He isn’t going to drive his dumper truck to its doom. He wants to use it as a weapon.
COMMENTS